Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG. Bjermer L, et al. Among authors: fabbri lm. BMJ. 2003 Oct 18;327(7420):891. doi: 10.1136/bmj.327.7420.891. BMJ. 2003. PMID: 14563743 Free PMC article. Clinical Trial.
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma.
Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, Casale TB, Chan-Yeung M, Chen R, Chowdhury B, Chung KF, Dahl R, Drazen JM, Fabbri LM, Holgate ST, Kauffmann F, Haahtela T, Khaltaev N, Kiley JP, Masjedi MR, Mohammad Y, O'Byrne P, Partridge MR, Rabe KF, Togias A, van Weel C, Wenzel S, Zhong N, Zuberbier T. Bousquet J, et al. Among authors: fabbri lm. J Allergy Clin Immunol. 2010 Nov;126(5):926-38. doi: 10.1016/j.jaci.2010.07.019. J Allergy Clin Immunol. 2010. PMID: 20926125
Asthma in the elderly: what we know and what we have yet to know.
Yáñez A, Cho SH, Soriano JB, Rosenwasser LJ, Rodrigo GJ, Rabe KF, Peters S, Niimi A, Ledford DK, Katial R, Fabbri LM, Celedón JC, Canonica GW, Busse P, Boulet LP, Baena-Cagnani CE, Hamid Q, Bachert C, Pawankar R, Holgate ST. Yáñez A, et al. Among authors: fabbri lm. World Allergy Organ J. 2014 May 30;7(1):8. doi: 10.1186/1939-4551-7-8. eCollection 2014. World Allergy Organ J. 2014. PMID: 25152804 Free PMC article. Review.
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD.
Voorham J, Corradi M, Papi A, Vogelmeier CF, Singh D, Fabbri LM, Kerkhof M, Kocks JH, Carter V, Price D. Voorham J, et al. Among authors: fabbri lm. ERJ Open Res. 2019 Aug 30;5(3):00106-2019. doi: 10.1183/23120541.00106-2019. eCollection 2019 Jul. ERJ Open Res. 2019. PMID: 31497610 Free PMC article.
Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study.
Voorham J, Baldi S, Santoro L, Kerkhof M, Contoli M, Fabbri LM, Kerstjens HAM, Luis López-Campos J, Roche N, Singh D, Vogelmeier CF, Price DB. Voorham J, et al. Among authors: fabbri lm. Int J Chron Obstruct Pulmon Dis. 2020 Oct 29;15:2739-2750. doi: 10.2147/COPD.S269287. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33149571 Free PMC article.
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone.
Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HAM, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G. Price DB, et al. Among authors: fabbri lm. Int J Chron Obstruct Pulmon Dis. 2022 Feb 15;17:355-370. doi: 10.2147/COPD.S342357. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35210765 Free PMC article.
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.
Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HAM, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G. Price D, et al. Among authors: fabbri lm. Pragmat Obs Res. 2024 Jan 20;15:1-16. doi: 10.2147/POR.S438031. eCollection 2024. Pragmat Obs Res. 2024. PMID: 38274639 Free PMC article.
446 results